Abstract
The establishment of a cell culture system for the clonal development of hematopoietic cells made it possible to discover the proteins that regulate cell viability, multiplication and differentiation of different hematopoietic cell lineages and the molecular basis of normal and abnormal development in blood-forming tissues (reviewed in [1–5]). These regulators include cytokines now called colony stimulating factors (CSFs) and interleukins (ILs) and hematopoiesis is controlled by a network of cytokine interactions [1–7]. This multigene network includes positive regulators such as CSFs and ILs and negative regulators such as transforming growth factor β and tumor necrosis factor. The cytokine network which has arisen during evolution allows considerable flexibility depending on which part of the network is activated and the ready amplification of response to a particular stimulus. Hematopoietic cytokines can induce the expression of transcription factors [8]. Cytokine signalling through transcription factors can thus ensure the autoregulation and transregulation of cytokine genes that occur in the network.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sachs L (1987) The molecular control of blood cell development. Science 238:1374–1379
Sachs L (1990) The control of growth and differentiation in normal and leukemic blood cells. The 1989 Alfred P Sloan Prize of the General Motors Cancer Research Foundation. Cancer 65:2196–2206
Sachs L (1992) The molecular control of hematopoiesis: From clonal development in culture to therapy in the clinic. Int J Cell Cloning 10:196–204
Sachs L (1993) The molecular control of hemopoiesis and leukemia. CR Acad Sci Paris, Sciences de la vie 316:882–891
Sachs L (1995) The adventures of a biologist: Prenatal diagnosis, hematopoiesis, leukemia, carcinogenesis and tumor suppression. Foundations in Cancer Research. Advances Cancer Research 66:1–40
Lotem J, Shabo Y, Sachs L (1991) The network of hematopoietic regulatory proteins in myeloid cell differentiation. Cell Growth Differ 2:421–427
Blatt C, Lotem J, Sachs, L (1992) Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene. Cell Growth Differ 3:671–676
Shabo Y, Lotem J, Sachs L (1990) Induction of genes for transcription factors by normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells. Leukemia 4:797–801
Lotem J, Cragoe EJ, Sachs L (1991) Rescue from programmed cell death in leukemic and normal myelpid cells. Blood 78:953–960
Lotem J, Sachs L (1992) Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750–1757
Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 82:15–21
Sachs L, Lotem, J (1995) Apoptosis in the hemopoietic system. In: Gregory CD (ed) Apoptosis and the Immune Response. Wiley, New York, pp 371–403
Lotem J, Sachs L (1995) Interferon-γ inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells. Leukemia 9:685–692
Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin 6. Nature 352:345–347
Lotem J, Sachs L (1993) Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells. Cell Growth Differ 4:41–47
Lotem J, Sachs L (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82:1092–1096
Lotem J, Sachs L (1994) Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Differ 5:321–327
Lotem J, Sachs L (1995) Regulation of bcl-2, bcl-XLand bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 6:647–653
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Sachs, L. (1996). Molecular Control of Development in Normal and Leukemic Myeloid Cells by Cytokines, Tumor Suppressor and Oncogenes. In: Wolff, L., Perkins, A.S. (eds) Molecular Aspects of Myeloid Stem Cell Development. Current Topics in Microbiology and Immunology, vol 211. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85232-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-85232-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85234-3
Online ISBN: 978-3-642-85232-9
eBook Packages: Springer Book Archive